Lung Cancer News

CancerConnect lung cancer news, tips, and features provide breaking research stories, helpful tips, and inspiring features related to ovarian cancer. The unique daily cancer news service evaluates all aspects of lung cancer research and reports on the developments that are most important to cancer patients and healthcare providers, while the tips and features offer insight into all aspects of lung cancer treatment and survivorship.

Share

Lung Cancer News


National Lung Cancer Awareness Month on CancerConnect (November 7, 2014)

November 7, 2014 Sun Valley, ID & Fort Worth, TX—OMNI Health Media (OMNI) announces the launch of lung cancer programs for national lung cancer awareness month. As the month of November brings lung... Continue Reading

Chest Radiation Improves Survival in Extended-Stage Small Cell Lung Cancer (November 4, 2014)

The results of a recently reported clinical study at the 56th Annual Meeting of the American Society for Radiation Oncology (ASTRO) in San Francisco demonstrate that thoracic radiation improves survival... Continue Reading

OMNI-Connect Gets National Recognition as Valuable Social Media Solution in Medicine (August 13, 2014)

Fort Worth TX/Sun Valley ID – OMNI Health Media announces national recognition of its online support communities, TheGIConnection,TheRAConnection, and Cancer Connect, as valuable resources for... Continue Reading

Cyramza With Taxotere Offers Modest Increase in Overall Survival in NSCLC (June 5, 2014)

A phase III randomized trial has shown that Cyramza™ (ramucirumab) combined with Taxotere® (docetaxel) extended overall survival 1.4 months in patients with non-small cell lung cancer (NSCLC) when compared... Continue Reading

Study Using Comprehensive Genomic Tumor Testing to Match Lung Cancer Patients with Targeted Therapies Transforms Care (May 22, 2014)

Data Supports Routine Tumor Genotyping for Patients with Advanced Lung Cancers; May Improve Survival New data from a study led by Memorial Sloan Kettering physicians that used targeted therapy for patients... Continue Reading

CO-1686 Lung Cancer Treatment Receives Breakthrough Designation by FDA (May 21, 2014)

Lung cancer remains the leading cause of cancer-related deaths worldwide. In the United States, NSCLC accounts for 75–80% of all lung cancers. Although progress has been made in recent years the majority... Continue Reading

Nintedanib Plus Docetaxel is Effective Second-Line Therapy for NSCLC (March 6, 2014)

Nintedanib in combination with docetaxel is an effective second-line option for patients with advanced non-small cell lung cancer previously treated with one line of platinum-based therapy, according to... Continue Reading

Lung Cancer Screening with Low-Dose CT Scan May Lead to Overdiagnosis (December 26, 2013)

Screening for lung cancer with low-dose CT scan may lead to overdiagnosis, according to the results of a study published in JAMA Internal Medicine. Lung cancer is the leading cause of cancer death among... Continue Reading

Marriage May Have a Protective Effect for Cancer Patients (December 17, 2013)

Social support may have a significant impact on cancer detection, treatment, and survival, according to the results of a study published in the Journal of Clinical Oncology. The study showed that married... Continue Reading

End-of-Life Care Remains Aggressive, Despite Patient Wishes (September 16, 2013)

Although most patients with advanced cancer prefer hospice or palliative care that minimizes symptoms, many continue to receive aggressive treatment during their final weeks and months of life. In fact,... Continue Reading

More Lung Cancer News

Latest Lung Cancer News By Stage


General

National Lung Cancer Awareness Month on CancerConnect (November 7, 2014)

November 7, 2014 Sun Valley, ID & Fort Worth, TX—OMNI Health Media (OMNI) announces the launch of lung cancer programs for national lung cancer awareness month. As the month of November brings lung cancer into focus, it’s time to increase public... Continue Reading

Chest Radiation Improves Survival in Extended-Stage Small Cell Lung Cancer (November 4, 2014)

The results of a recently reported clinical study at the 56th Annual Meeting of the American Society for Radiation Oncology (ASTRO) in San Francisco demonstrate that thoracic radiation improves survival and reduces cancer recurrence when added to prophylactic... Continue Reading

Cyramza With Taxotere Offers Modest Increase in Overall Survival in NSCLC (June 5, 2014)

A phase III randomized trial has shown that Cyramza™ (ramucirumab) combined with Taxotere® (docetaxel) extended overall survival 1.4 months in patients with non-small cell lung cancer (NSCLC) when compared to standard second-line therapy (Taxotere... Continue Reading

Nintedanib Plus Docetaxel is Effective Second-Line Therapy for NSCLC (March 6, 2014)

Nintedanib in combination with docetaxel is an effective second-line option for patients with advanced non-small cell lung cancer previously treated with one line of platinum-based therapy, according to the results of a study published in The Lancet Oncology. Lung... Continue Reading

Lung Cancer Screening with Low-Dose CT Scan May Lead to Overdiagnosis (December 26, 2013)

Screening for lung cancer with low-dose CT scan may lead to overdiagnosis, according to the results of a study published in JAMA Internal Medicine. Lung cancer is the leading cause of cancer death among both men and women in the United States. The disease... Continue Reading

More General

CancerConnect Cancer Commuity & Discussions


Cancer Types

Sign up for the CancerConnect newsletter

Sign up for our newsletter and receive the latest news and updates about specific types of cancer.

  Close |  Please don't show me this again

Just another WordPress weblog
Facebook Twitter RSS